| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |